Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy.
Gold nanoparticle accumulation in immune cells has commonly been viewed as a side effect for cancer therapeutic delivery; however, this phenomenon can be utilized for developing gold nanoparticle mediated immunotherapy. Here, we conjugated a modified CpG oligodeoxynucleotide immune stimulant to gold...
Main Authors: | Adam Yuh Lin, Joao Paulo Mattos Almeida, Adham Bear, Nathan Liu, Laureen Luo, Aaron Edward Foster, Rebekah Anna Drezek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3655178?pdf=render |
Similar Items
-
T cells enhance gold nanoparticle delivery to tumors <it>in vivo</it>
by: Bear Adham, et al.
Published: (2011-01-01) -
CpG-Based Nanovaccines for Cancer Immunotherapy
by: Chen W, et al.
Published: (2021-08-01) -
The implication of Src in CpG-induced macrophage migration
by: Yu-Yun Li, et al.
Published: (2008) -
Immunostimulatory effects and delivery of oligodeoxynucleotides containing CpG motifs (CpG-ODN) in neonatal broiler chickens
by: Joze Taghavi Shirazi, Azita
Published: (2008) -
CpG Oligonukleotide:
by: Wagner, Moritz
Published: (2007)